Background: Exercise limitation is a hallmark of chronic obstructive pulmonary disease (COPD) and is integral to the associated impaired health status of these patients. The poor exercise tolerance is multifactorial in origin, relating to airflow obstruction, disadvantageous lung mechanics, reduced oxygen delivery and skeletal muscle dysfunction. A number of interventions have been studied to determine whether they can impact on exercise performance. The most evidence-based of these is exercise training, which along with other approaches, both previously investigated and putative, are discussed in this review. Chronic Respiratory Disease 2004; 1: 95-98
Exercise intolerance is a hallmark of chronic obstructive pulmonary disease (COPD) and contributes to the disabling consequences of the 'dyspnoea spiral'. The skeletal muscle mitochondrion is the final endpoint in the oxygen delivery cascade from lung, via blood, that generates the energy for movement.1 In COPD there are a number of processes occurring that affect exercise performance through mechanisms apart from the classically recognized effects of ventilatory [2] [3] [4] [5] limitation.
In particular, increased understanding of the alterations in the skeletal muscle of patients with COPD has furthered our knowledge of the disability seen in this patient group.6 Standardized measures of exercise performance, whether by paced shuttle walks, timed walking distances or laboratory tests are now well-established outcome measures in clinical practice.7 There is increasing understanding of the magnitude of improvement that is clinically meaningful for individual patients.10 Potentially as valid, other measures of perfornance include specific questionnaires or domiciliary activity monitors.11 '12 In this review we shall examine the benefit of targeted interventions for the main pathological processes that influence exercise performance in COPD, with particular reference to the skeletal muscle.
We shall also speculate on the potential for the use of agents that have yet to have a proven role and consider direction of future research.
Oxygen supplementation
Oxygen is essential for successful aerobiasis in the skeletal muscle; however, the benefit for the majority of COPD patients of increasing the inspired fraction of oxygen is unclear. Continuous or short-burst oxygen supplementation has no clear impact upon patients who do not have hypoxia. 13 The short-term effects for those patients who are hypoxic at rest or desaturate on exercise are well established.14'15 Endurance activity and breathlessness are improved, which has led to strong lobbying for the provision of portable, liquid oxygen to COPD patients; however, uncertainty still surrounds the utility of oxygen supplementation during exercise training.
Reduced work of breathing
Traditionally, lung abnormalities are seen to present largely irreversible and overwhelming barriers to exercise through the imposition of a 'ventilatory ceiling'. Inhaled therapies have relatively little impact on FEVI, as expected through the definition of the disease, but other parameters such as inspiratory capacity are more responsive to the effects of bronchodilatation. 18 20 Moreover, bronchodilators can be seen to significantly ameliorate the incapacitating consequences of ever-diminishing inspiratory capacities during exercise in COPD patients.2' Studies are under way to demonstrate that shortand long-acting bronchodilators slow down the increase of work of breathing, with clear benefits expected upon symptoms and exercise performance. One intervention that can dramatically alter lung function and thereby impact upon exercise capacity is lung volume reduction surgery. The role of this treatment and appropriate selection of patients have recently been much better clarified. 23 Offloading the respiratory muscles, through the application of noninvasive ventilation during exercise, increases performance.2425 This is possibly due to reduction of 'the respiratory steal' of blood flow from the skeletal muscle during exercise.3
Exercise training
A large evidence base has established that pulmonary rehabilitation, which must include endurance or strength muscle training, leads to clear and reproducible improvements in breathlessness, health status and exercise capacity. 26, 27 Relatively low intensity programmes have been shown to be effective.28 In more severe patients, physical training of muscles may be supplemented by direct electrical stimulation with clear exercise performance benefits.29 The mechanisms behind the benefits seen in exercise performance and health status are becoming clearer: although the development of tolerance to symptoms during training probably is important, it is now known that physiological changes within the skeletal muscle are occurring that relate to the improvements seen.30'31 A number of abnormalities have been described in the skeletal muscle of patients with COPD, such as selective loss of type 2b fibres, decreased levels of oxidative enzymes and increased local oxidative stress.6'32 Some of these abnormalities are partially ameliorated following exercise training.33-6 Also, skeletal muscle mass has been shown to be a strong independent predictor ofmortality in this patient group. The aetiology of this is likely to be multifactorial, with disuse atrophy, cellular hypoxia, circulating inflammatory cytokines and malnutrition playing putative roles, thereby suggesting a number of potential targeted interventions for this problem.
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Nutritional supplementation
The importance of nutritional support for patients with COPD is widely accepted, and under well-controlled conditions, refeeding trials in malnourished patients with stable COPD have been successful in improving nutritional status and respiratory muscle strength.37-40 The benefits have not been universal, as demonstrated by negative studies of some outpatient supplementation programmes, the latter leading to a disappointing conclusion of inefficacy of nutritional supplementation of a Cochrane review. Two studies have combined nutritional intervention with exercise training. Schols et al. 49 combined nutritional supplementation with rehabilitation and demonstrated significant weight gains for underweight patients (albeit in fat mass) in the supplemented group. None of the patients increased walking distance above those who received rehabilitation alone, but physical performance was not the primary outcome of the study. Steiner et al. randomized 85 patients to either a high calorific supplement or placebo during a standard exercise programme.44 There was no overall benefit of supplementation on exercise capacity above that achieved through rehabilitation. However, in the well-nourished subgroup there were significantly greater improvements seen in shuttle walk distance, the magnitude of effect correlating with increases in total carbohydrate intake.
Pharmacological agents
Administration of the recombinant human growth hormone (rhGH) induces lipolysis, protein anabolism, and muscle growth, either directly or through insulinlike growth factor-I (IGF-1).45'46 Two studies reported the effects of rhGH in under-nourished patients with COPD, but neither was placebo controlled, no exercise training component was involved, and no effects on exercise capacity were demonstrated.47 '48 The parenteral anabolic-androgenic steroid nandrolone decanoate has been shown to increase fat-free mass in COPD patients in both the context of inpatient and outpatient rehabilitation settings, without demonstrable improvements in exercise capacity.49,50 However, nandrolone requires parenteral administration, does not have a high separation of anabolic and androgenic effects, and is not approved for weight restoration. Oxandrolone is an oral anabolic steroid approved as an adjunct to help restore weight in some groups of patients who have lost weight. An open label four-month trial found that use of oxandrolone was associated with increased 6MWD of >65 m in the majority of the 82 patients enrolled.5
Conclusion
There is evidence supporting the use of some aids to physical performance in COPD, as outlined in this review. However, a large number of potential therapies that may improve nutritional status or muscle function exist. In a randomized double-blind trial, creatine led to significantly greater improvements in peripheral muscle strength and endurance.52 Other options range from simple dietary supplements, through nutriceuticals such as antioxidants or specific amino acids or anabolic agents. 53 However, research in this area is bedevilled by methodological problems, with few randomized controlled studies or prospective cohort studies. In comparison to classic drug trials, numbers enrolled are often small and follow-up is short. A number of methodological issues need to be addressed in terms of measuring improved performance. It is likely most ergogenic therapies will have greatest effect in combination with an exercise-based rehabilitation programme, although there may be benefits for those unable to participate in a standard programme due to severity of disease or comorbidities. Ideally, studies should include measures of adherence to the regimen, and be able to measure a hierarchy of effects, from individual muscle function to whole body exercise tests, body composition and activity domains of quality of life scores and activities of daily living. Investigations should include a follow-up period at the end of the intervention if this is to be discontinued to allow some estimate of duration of effect. Novel agents should be studied using a protocol that will allow some estimate of possible side effects to be made. Finally large, long-duration studies will need to be carried out to look at morbidity and mortality and allow for health economic evaluations.
